Top Stories Evercore ISI Adjusts Abbott’s Price Target Amid Mixed Results Abbott Laboratories (NYSE:ABT) faced a significant adjustment from Evercore ISI, which lowered its price target from $144 to $138 on January 23, 2024. Despite... Editorial6 days ago